Bluesphere Bio, Inc
Clinical trials sponsored by Bluesphere Bio, Inc, explained in plain language.
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goals are to check safety and see if it can prevent the cancer from coming …
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New immune cell therapy aims to prevent leukemia return after transplant
Disease control Recruiting nowThis early-phase trial tests a new cell therapy called BSB-1001 in 38 adults with high-risk blood cancers (AML, ALL, or MDS) who are getting a stem cell transplant. BSB-1001 is made from donor immune cells that are modified to attack a specific marker on cancer cells. The goal is…
Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Jun 26, 2026 18:25 UTC